Evidence map›Paper›PMID 29885494›Full record

ArticleJournal of cardiac failure2018

In-Hospital and Three-Year Outcomes of Heart Failure Patients in South India: The Trivandrum Heart Failure Registry.

Ganapathi Sanjay, Panniyammakal Jeemon, Anubha Agarwal, Sunitha Viswanathan, Madhu Sreedharan, Govindan Vijayaraghavan, Charantharayil Gopalan Bahuleyan, R Biju, Tiny Nair, N Prathapkumar and 6 more

Abstract readMulticenter Study
In one paragraph

Article in Journal of cardiac failure, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ganapathi SanjaySree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India. Electronic address: drsanjayganesh@gmail.com.
Panniyammakal JeemonSree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.
Anubha AgarwalDepartment of Medicine, Duke University Medical Center, Durham, North Carolina; Duke Global Health Institute, Duke University, Durham, North Carolina.
Sunitha ViswanathanGovernment Medical College Hospital, Trivandrum, Kerala, India.
Madhu SreedharanNIMS Hospital, Kerala, India.
Govindan VijayaraghavanKIMS Hospital, Trivandrum, Kerala, India.
Charantharayil Gopalan BahuleyanAnanthapuri Hospitals, Kerala, India.
R BijuCosmopolitan Hospitals, Kerala, India.
Tiny NairPRS Hospital, Kerala, India.
N PrathapkumarMeditrina Hospital, Kerala, India.
G KrishnakumarGovindan's Hospital, Kerala, India.
N RajalekshmiSUT Hospital, Kerala, India.
Krishnan SureshSK Hospital, Trivandrum, Kerala, India.
Lawrence P ParkDepartment of Medicine, Duke University Medical Center, Durham, North Carolina; Duke Global Health Institute, Duke University, Durham, North Carolina.
Mark D HuffmanDepartment of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Sivadasanpillai HarikrishnanSree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, Kerala, India.

Funding

Partnership for Global Health Research Training Program (Renewal)-Supplement for OBSSR, NCI, NCI-AIDS and NIDCDD43TW010543 · FIC · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI Wafaie W Fawzi, DAVIDSON HOWES HAMER · 2017 to 2026
$12.1M
FIC NIH HHS D43 TW010543
6 · The paper itself

Abstract

backgroundLong-term data on outcomes of participants hospitalized with heart failure (HF) from low- and middle-income countries are limited. METHODS AND

resultsIn the Trivandrum Heart Failure Registry (THFR) in 2013, 1205 participants from 18 hospitals in Trivandrum, India, were enrolled. Data were collected on demographics, clinical presentation, treatment, and outcomes. We performed survival analyses, compared groups and evaluated the association between heart failure (HF) type and mortality, adjusting for covariates that predicted mortality in a global HF risk score. The mean (standard deviation) age of participants was 61.2 (13.7) years. Ischemic heart disease was the most common cause (72%). The in-hospital mortality rate was higher for participants with HF with reduced ejection fraction (HFrEF; 9.7%) compared with those with HF with preserved ejection fraction (HFpEF; 4.8%; P = .003). After 3 years, 540 (44.8%) participants had died. The all-cause mortality rate was lower for participants with HFpEF (40.8%) compared with HFrEF (46.2%; P = .049). In multivariable models, older age (hazard ratio [HR] 1.24 per decade, 95% confidence interval [CI] 1.15-1.33), New York Heart Association functional class IV symptoms (HR 2.80, 95% CI 1.43-5.48), and higher serum creatinine (HR 1.12 per mg/dL, 95% CI 1.04-1.22) were associated with all-cause mortality.

conclusionsParticipants with HF in the THFR have high 3-year all-cause mortality. Targeted hospital-based quality improvement initiatives are needed to improve survival during and after hospitalization for HF.

Indexed as

RegistriesCause of DeathFemaleFollow-Up StudiesHeart FailureHospitalizationHospital MortalityHospitalsHumansIncidenceIndiaMaleMiddle AgedPrognosisProspective StudiesRisk FactorsHeart failureIndiaregistry

Identifiers

PMID29885494
PMCPMC7263011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.